|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current assets: | |||||||||
| Cash | |||||||||
| Prepaid expenses | |||||||||
| Total current assets | |||||||||
| Deferred offering costs | |||||||||
| Prepaid expenses, non - current | |||||||||
| Investments held in Trust Account | |||||||||
| Total Assets | |||||||||
| Liabilities and Stockholders' Deficit | |||||||||
| Current liabilities: | |||||||||
| Accrued offering costs and expenses | |||||||||
| Promissory note-related party | |||||||||
| Accounts payable and accrued liabilities | |||||||||
| Excise tax payable | |||||||||
| Income taxes payable | |||||||||
| Promissory Note - Related Party | |||||||||
| Due to related party | |||||||||
| Total current liabilities | |||||||||
| Deferred underwriting commissions | |||||||||
| Total Liabilities | |||||||||
| Class A common stock subject to possible redemption, 4,943,226 and 27,600,000 shares at redemption value as of September 30, 2023 and December 31, 2022, respectively | |||||||||
| Common Class A | |||||||||
| Total class A common stock subject to possible redemption, 4,943,226 and 27,600,000 shares at redemption value as of September 30, 2023 and December 31, 2022, respectively | |||||||||
| Stockholders' Deficit: | |||||||||
| Preferred stock, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding | |||||||||
| Common stock value | |||||||||
| Common Class A | |||||||||
| Common Class B | |||||||||
| Stock subscription receivable | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| Total Stockholders' Deficit | |||||||||
| Total Liabilities, Common Stock subject to redemption and Stockholders' Deficit |
Loading...
